GlaxoSmithKline Pakistan Cash Flow Statement

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	9,187	6,536	533.95	2,463	5,354	3,375
Depreciation & Amortization	1,309	1,136	932.3	859.38	775.27	761.5
Loss (Gain) From Sale of Assets	-54.51	-21.88	-82.76	-124.62	-633.9	-17.21
Asset Writedown & Restructuring Costs	18.39	18.39	6.01	18.02	15.54	30.81
Provision & Write-off of Bad Debts	1.76	1.76	160.34	89.7	42.74	-30.5
Other Operating Activities	368.22	1,552	-703.15	-431.51	1,204	679.82
Change in Accounts Receivable	-30.3	471.58	395.71	-358.67	-154.15	-37.98
Change in Inventory	-2,064	-365.39	-2,256	-3,363	-1,077	180.77
Change in Accounts Payable	-1,316	-1,009	4,332	2,827	-36.69	956.95
Change in Other Net Operating Assets	-293.68	-3,257	-1,386	-5,142	-512.05	30.39
Operating Cash Flow	7,139	5,058	1,884	-3,161	4,987	5,960
Operating Cash Flow Growth	14.87%	168.51%	-	-	-16.33%	132.28%
Capital Expenditures	-2,761	-2,775	-1,649	-1,533	-1,304	-1,316
Sale of Property, Plant & Equipment	254.81	134.32	212.95	244.47	777.27	52.99
Other Investing Activities	474.7	538.91	279.45	827.1	374.94	237.1
Investing Cash Flow	-2,032	-2,102	-1,157	-461.6	-151.56	-1,026
Long-Term Debt Repaid	-	-51.12	-25.59	-14.6	-11.46	-12.09
Net Debt Issued (Repaid)	-51.23	-51.12	-25.59	-14.6	-11.46	-12.09
Common Dividends Paid	-4,741	-1.76	-1,845	-375.03	-2,062	-1,892
Financing Cash Flow	-4,792	-52.88	-1,871	-389.63	-2,073	-1,904
Net Cash Flow	314.26	2,903	-1,144	-4,012	2,762	3,031
Free Cash Flow	4,377	2,282	234.56	-4,694	3,683	4,644
Free Cash Flow Growth	9.33%	873.04%	-	-	-20.69%	279.89%
Free Cash Flow Margin	7.05%	3.73%	0.47%	-11.22%	10.05%	13.23%
Free Cash Flow Per Share	13.74	7.17	0.74	-14.74	11.57	14.58
Cash Interest Paid	-	-	-	-	-	8.86
Cash Income Tax Paid	5,714	2,698	2,309	2,639	871.59	810
Levered Free Cash Flow	5,014	3,051	-1,126	-1,473	3,545	4,278
Unlevered Free Cash Flow	5,014	3,063	-1,122	-1,470	3,549	4,282
Change in Working Capital	-3,704	-4,160	1,085	-6,036	-1,780	1,130

Source: S&P Global Market Intelligence. Standard template. Financial Sources.